User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Clinico-biochemical aspects of guanidine compounds in uraemic toxicity.

Primary tabs

Kishore, B K Kállay, Z Tulkens, Paul M. [UCL]

"Uraemia" literally means "urine in blood". With the advancement of basic medical sciences, it is being better understood. The clinical syndrome of uraemia is due to the failure of not only the excretory but also the metabolic, regulatory and endocrine functions of the kidney. Apart from the "retained toxic metabolites", a number of guanidine derivatives had been found which are now considered to be more important in the causation of the uraemic syndrome. Cohen had hypothesised that nitrogen retention in uraemia causes an aberration in the urea cycle that in turn leads to the production of guanidinosuccinic acid (GSA) in large amounts. However, it appears that methylguanidine (MG) is produced from the degradation of creatinine by the gut flora in uraemics. Both GSA and MG are proved to be toxic. The role of GSA in uraemic neurotoxicity and coma is still controversial and needs further investigation. It is possible that the combined effects of a number of compounds are responsible for the development of the uraemic syndrome.

Document type Article de périodique (Journal article) – Journal Article, Research Support, Non-U.S. Gov't, Review
Publication date 1989
Journal information "International urology and nephrology" - Vol. 21, no. 2, p. 223-32 (1989)
Peer reviewed yes
issn 0301-1623
Publication status Publié
Affiliation UCL
MESH Subject Guanidines - analysis - metabolism - pharmacology ; Humans ; Nervous System Diseases - etiology ; Uremia - complications - metabolism
Links
  1. Piorry, PA., L’Heritier, D.: Traite des alterations du sang. Ballière, Paris 1840.
  2. Astoin, M., Hornych, A., Meyer, P.: Prostaglandins in nephrology.Adv. Nephrol., 4, 142 (1974).
  3. Knochel, J. P., Seldin, D. W.: The pathophysiology of uremia. In: Brenner, B. M., Rector, F. C. (eds): The Kidney. Vol. II. W. B. Saunders Co., Philadelphia 1976, pp. 1448–1480.
  4. Bergström, J., Fürst, P.: Uremic toxins. In: Drukker et al. (eds): Replacement of Renal Function by Dialysis. Martinus Nijhoff Medical Division, The Hague 1978.
  5. Horowitz, H. I., Stein, I. M., Cohen, B. D., Bronx, N. Y.: Further studies on the platelet inhibitory effect of GSA and its role in uremic bleeding.Am. J. Med., 49, 336 (1970).
  6. Cohen, B. D., Stein, I. M., Bones, J. E.: Guanidinosuccinic aciduria in uremia, a possible alternate pathway for urea synthesis.Am. J. Med., 45, 63 (1968).
  7. Cohen, B. D.: Guanidine retention and urea cycle. Proc. 4th Int. Congr. Nephrol. 1969, p. 34.
  8. Rey, A. P. G., Schiff, E.: The biosynthesis of guanidinosuccinic acid by perfused rat livers.J. Clin. Invest., 57, 807 (1976).
  9. Kishore, B. K.: Some Biochemical Studies in Renal Failure. MD Thesis, Banaras Hindu University (India), 1980.
  10. Hoppe-Seyler, G., Schollmyer, M. K. P., Frochich, J., Gerok, G. W.: Studies of urea cycle enzymes in rat livers during acute uremia.Eur. J. Clin. Invest., 5, 15 (1975).
  11. Giovannetti, S., Biagini, M., Balestri, P. L.: Uremia-like syndrome in dogs chronically intoxicated with methylguanidine and creatinine.Clin. Sci., 36, 445 (1969).
  12. Perez, G., Faluotico, R.: Creatinine: A precursor of methylguanidine.Experientia, 29, 1473 (1973).
  13. Gonella, M., Barsotti, G., Lupetti, S., Giovannetti, S., Campa, V.: Falcone, G.: Role of the aerobic gut flora on the creatinine and methylguanidine metabolism. In: Proc. 6th Int Congr. Nephrol., Florence, S. Karger, Basel 1976.
  14. Jones, D. J., Burnett, P. C.: Creatinine metabolism and toxicity.Kidney Int., 7 (Suppl. 3), 295 (1975).
  15. Simenoff, M. L.: Metabolism and toxicity of aliphatic amines.Kidney Int., 7 (Suppl. 3), 314 (1975).
  16. Simenoff, M. L., Sankkonew, J. J., Burke, J. F.: Importance of aliphatic amines in uremia.Kidney Int., 13 (Suppl. 8), 16 (1978).
  17. Gejyo, F., Baba, S., Watanabe, Y., Kishore, B. K., Suzuki, Y., Arakawa, M.: Possibility of a common metabolic pathway for the production of methylguanidine and dimethylamine in chronic renal failure. In: Mori, A., Cohen, B. D., Lowenthal, A. (eds): Guanidines. Proc. Int. Symp. on Guanidine Compounds, Tokyo. Plenum Press New York 1985.
  18. Horowitz, H. I.: Uremic toxins and platelet function.Arch. Intern. Med., 7, 823 (1970).
  19. Slavin, R. D., Fitch, C. D.: Inhibition of lymphocyte transformation by guanidinosuccinic acid, a surplus metabolite in uremia.Experientia, 27, 1340 (1971).
  20. de Wardener, H. E.: The Kidney. Churchill Livingstone, Edinburgh, 1973.
  21. Giovannetti, S., Biagini, M., Cioni, L.: Evidence that methylguanidine is retained in chronic renal failure.Experientia, 24, 341 (1968).
  22. Arieff, A. I., Guisado, R.: Effects on the central nervous system of hyponatremic and hypernatremic states.Kidney Int., 10, 104 (1976).
  23. Giordano, C., Crescenzi, A.: Riduzione del consumo di ossigeno di feetine ed amogenati di oranoda parte dell’urea.Boll. Soc. Ital. Bio. Sper., 37, 1199 (1961).
  24. Davidoff Frank, Effects of guanidine derivatives on mitochondrial function, 10.1172/jci105918
  25. Lascelles, P. T., Taylor, W. H.: The effect upon tissue respirationin vitro of metabolites which accumulate in uremic coma.Clin. Sci., 31, 403 (1966).
  26. Kishore, B. K.: Some observations on thein vivo andin vitro effects of guanidinosuccinic acid on the nervous system of laboratory animals.Acta Med. Bio. (Japan),31, 79 (1983).
Bibliographic reference Kishore, B K ; Kállay, Z ; Tulkens, Paul M.. Clinico-biochemical aspects of guanidine compounds in uraemic toxicity.. In: International urology and nephrology, Vol. 21, no. 2, p. 223-32 (1989)
Permanent URL http://hdl.handle.net/2078.1/11627